Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target

Secretory clusterin (sCLU) is associated with hepatocellular carcinoma (HCC) progression by contributing to angiogenesis, chemoresistance, cell survival, and metastasis. However, the sCLU expression at early stage of HCC progression remains to be clarified. In this study, the alteration of sCLU onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wenjie, Yao, Min, Qian, Qi, Sai, Wenli, Qiu, Liwei, Yang, Junling, Wu, Wei, Dong, Zhizhen, Yao, Dengfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581031/
https://www.ncbi.nlm.nih.gov/pubmed/28881732
http://dx.doi.org/10.18632/oncotarget.13674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581031/
https://www.ncbi.nlm.nih.gov/pubmed/28881732
http://dx.doi.org/10.18632/oncotarget.13674

Ejemplares similares